Thus the TGFB2 gene was identified as a candidate gene to CM susceptibility in a genetic cross that used wild-derived mouse strains and where CM susceptibility segregated from hyperparasitaemia [42], suggesting that TGFB2 would be a gene conferring risk to CM in the context of severe malaria. This evidence concerns the gene TGFB2 and cutaneous mastocytosis.